Addus HomeCare (NASDAQ:ADUS) EVP Sean Gaffney Sells 817 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Sean Gaffney sold 817 shares of the company’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $87,402.66. Following the completion of the transaction, the executive vice president owned 20,522 shares in the company, valued at $2,195,443.56. This represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Sean Gaffney also recently made the following trade(s):

• On Wednesday, February 25th, Sean Gaffney sold 442 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total transaction of $46,569.12.

Addus HomeCare Stock Down 0.7%

ADUS stock opened at $103.29 on Friday. The company has a 50 day moving average of $109.41 and a two-hundred day moving average of $113.01. The company has a market cap of $1.91 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 1.49 and a beta of 0.91. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of recent research reports. Truist Financial set a $135.00 target price on Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. BMO Capital Markets started coverage on Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target for the company. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Trading of Addus HomeCare

A number of institutional investors and hedge funds have recently modified their holdings of the company. TimesSquare Capital Management LLC raised its holdings in Addus HomeCare by 6.2% in the 3rd quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after acquiring an additional 24,301 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Addus HomeCare by 10.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock worth $6,439,000 after acquiring an additional 5,110 shares during the period. Public Sector Pension Investment Board grew its holdings in shares of Addus HomeCare by 14.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock worth $8,357,000 after purchasing an additional 8,893 shares in the last quarter. Creative Planning grew its holdings in shares of Addus HomeCare by 150.9% during the 2nd quarter. Creative Planning now owns 7,024 shares of the company’s stock worth $809,000 after purchasing an additional 4,224 shares in the last quarter. Finally, Tributary Capital Management LLC increased its position in shares of Addus HomeCare by 114.1% during the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.